ARIA Overview
Upcoming Projects (ARIA)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (ARIA)
Upcoming & Overdue Catalysts (ARIA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ARIA)
-
PDUFA Date of April 29th for Ariad's (ARIA) Brigatinib in ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Tickers: TKPYY, ARIA
Occurred on: Apr 28, 2017 -
ARIAD (ARIA) Submits Marketing Authorization Application (MMA) in Europe for Adults with ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Ticker: ARIA
Occurred on: Feb 06, 2017 -
Ariad's (ARIA) New Drug Application for Brigatinib in ALK-Positive Non-Small Cell Lung Cancer Accepted for Review by FDA
Ticker: ARIA
Occurred on: Oct 31, 2016 -
ARIAD and Otsuka Submit New Drug Application in Japan for Ponatinib; decision expected in the second half of 2016.
Tickers: ARIA, OTK.F
Occurred on: Sep 28, 2016 -
Phase 2 dose ranging trial preliminary data of Iclusig (ponatinib) for thrid line chronic-phase CML (CP-CML) due end of 2016
Ticker: ARIA
Occurred on: Sep 15, 2016 -
ARIAD Completes Rolling Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration
Ticker: ARIA
Occurred on: Aug 30, 2016 -
ARIAD Initiates Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration Ahead of Plan
Ticker: ARIA
Occurred on: Jun 17, 2016 -
ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 PACE Clinical Trial
Ticker: ARIA
Occurred on: Jun 13, 2016
Strategic Initiatives (ARIA)
-
Takeda (TKPYY) Agrees to Acquire ARIAD Pharma (ARIA) for $5.2 Billion in Cash
Tickers: ARIA, TKPYY
Announcement Date: Jan 09, 2017 -
Incyte acquires the European operation of ARIAD Pharmaceuticals for $140M upfront plus milestones and tiered royalties
Tickers: INCY, ARIA
Announcement Date: May 09, 2016
